Our data present in this study showed that the expression of CSTF2 correlates to the shortening of 3′UTR of the differentially expressed genes in lung cancer, and the results from this study suggest a clinic potential of CSTF2 as a therapeutic target for lung cancer. The gene discussed is CSTF2; the disease is lung carcinoma.